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Abstract
 
As a resident of early endosomal phagosomes, 
 
Mycobacterium tuberculosis
 
 is connected to the iron
uptake system of the host macrophage. 
 

 
-2-microglobulin (
 

 
2m) knockout (KO) mice are
more susceptible to tuberculosis than wild-type mice, which is generally taken as a proof for
the role of major histocompatibility complex class I (MHC-I)–restricted CD8 T cells in protec-
tion against 
 
M. tuberculosis
 
. However, 
 

 
2m associates with a number of MHC-I–like proteins,
including HFE. This protein regulates transferrin receptor mediated iron uptake and mutations
in its gene cause hereditary iron overload (hemochromatosis). Accordingly, 
 

 
2m-deficient
mice suffer from tissue iron overload. Here, we show that modulating the extracellular iron
pool in 
 

 
2m–KO mice by lactoferrin treatment significantly reduces the burden of 
 
M. tubercu-
losis
 
 to numbers comparable to those observed in MHC class I–KO mice. In parallel, the gen-
eration of nitric oxide impaired in 
 

 
2m–KO mice was rescued. Conversely, iron overload in
the immunocompetent host exacerbated disease. Consistent with this, iron deprivation in in-
fected resting macrophages was detrimental for intracellular mycobacteria. Our data establish:
(a) defective iron metabolism explains the increased susceptibility of 
 

 
2m-KO mice over MHC-
I–KO mice, and (b) iron overload represents an exacerbating cofactor for tuberculosis.
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Introduction
 
Mycobacterium tuberculosis
 
 is a facultative intracellular bacte-
rium, which resides in macrophages in early endosomal
compartments. Characterization of the mycobacterial
phagosome has established that this compartment has access
to transferrin (Tf) and the transferrin receptor (TfR) and
thus to the iron (Fe) transport pathway of the host cell (1).
Access to the host iron source is crucial for mycobacterial
survival, as disconnecting their phagosomes from the Tf-
pathway by IFN-
 

 
 activation inhibits mycobacterial
growth (2). The notion that mycobacteria require Fe for
intracellular growth is also supported by their expression of
soluble high affinity Fe binding molecules, exochelins,
which capture Fe in the environment for its delivery to cell
wall associated siderophores (3).
The contribution of MHC-I–restricted CD8 T cells in
protection against tuberculosis has been deduced from ex-
periments showing that 
 

 
-2-microglobulin (
 

 
2m)–KO
mice are highly susceptible to 
 
M. tuberculosis
 
 when com-
pared with C57BL/6 (B6) mice (4). Surface expression of
MHC-I molecules requires 
 

 
2m, and consequently these
mice lack MHC-I–restricted CD8 T cells. However,
MHC-I KO mice (K
 
b
 
D
 
b
 
-KO) are far less susceptible to tu-
berculosis than 
 

 
2m–KO mice (5). Therefore, factors other
than the absence CD8 T cells must be involved in the
higher susceptibility of 
 

 
2m–KO mice. In addition to
molecules involved in antigen presentation, 
 

 
2m nonco-
valently associates with the MHC I homologue HFE,
which regulates Tf/TfR uptake and Fe release from Tf
inside recycling endosomes. In patients with hereditary
hemochromatosis HFE is nonfunctional as a result of sev-
eral point mutations which results in tissue iron overload
(6, 7). Here we show that 
 
M. tuberculosis
 
 infection is exac-
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erbated under Fe overload. Moreover, this defect can be
corrected by the administration of lactoferrin, which results
in the amelioration of bacterial burden.
 
Materials and Methods
 
Bacteria
 
M. tuberculosis
 
 (Erdman) and 
 
M. bovis
 
 BCG were grown in
Middlebrook medium (7H9; Difco) and harvested at a density of
 

 
2–4 
 

 
 10
 
8
 
/ml. For in vitro growth measurements, 5 ml 7H9
containing either 1 mg/ml Fe citrate (Fe
 
3
 

 
Ci; Sigma-Aldrich), 1
mg/ml bovine lactoferrin (Sigma-Aldrich/ICN Biomedicals), 0.5
mg/ml deferroxamine (ICN Biomedicals), or deferroxamine/
Fe
 
3
 

 
Ci together, were inoculated with 10
 
7
 
 
 
M. tuberculosis
 
. OD
 
600
 
or CFUs were determined as indicated.
 
Mice, Treatment, and Infection
 
Wild-type B6, 
 

 
2m-KO, and MHC-I KO mice (provided by
Dr. Lemonnier, Institute Pasteur, Paris, France; reference 8) were
bred under SPF conditions at the central animal facilities of the
Bundesinstitut für gesundheitlichen Verbraucherschutz und Vet-
erinärmedizin (Berlin, Germany). The KO mice were back-
crossed for at least 10 generations on the genetic background of
B6 mice. Mice were infected with 3–5 or 15–200 
 
M. tuberculosis
 
/
lung by aerosol using an aerosol chamber (Glas-Col). Inocula
were confirmed at day 1 after infection by plating the complete
lung onto Middlebrook 7H11/ampicillin plates. CFU in lung,
spleen, and liver were determined at the time points indicated by
mechanical disruption of the organs in water/1% albumin/0.5%
Tween 80 (WTA), and plating serial dilutions onto Middlebrook
7H11/ampicillin agar. Mice were treated twice a week intrana-
sally with 1 mg/mouse bovine lactoferrin (iron saturability, 72%;
Sigma-Aldrich), recombinant human lactoferrin (iron saturability
of 88.5%; provided by Dr. Pauline Ward, Baylor College, and
Dr. Karel Petrak, Agennix Inc., Houston, TX) or intraperito-
neally with deferroxamine in PBS or with PBS alone. To over-
load mice with iron, animals were given 25 mg/ml Fe
 
3
 

 
Ci in the
drinking water for the duration of the experiment.
 
Nitric Oxide Measurement
 
Nitric oxide was determined in sera from infected mice as
NO
 
2
 
 upon reduction of NO
 
3
 
 using the Griess-reaction as de-
scribed previously (9).
 
IFN-
 

 
 ELISA
 
Sera from infected mice were diluted in 96-well plates pre-
coated with anti–IFN-
 

 
 mAb R46A2 and blocked with 1% BSA.
After several washings, plates were incubated with the biotin-
ylated mAb XMG1.2 followed by peroxidase-coupled streptavi-
din and substrate. Recombinant murine IFN-
 

 
 (R&D Systems)
was applied as standard. The OD was measured at 560 nm. The
limit of detection was 1.5 U/ml.
 
Intramacrophage Killing Assay
 
Bone marrow cells from B6 or 
 

 
2m–KO mice were harvested
and differentiated to macrophages in L-cell supernatant (20%)
supplemented medium as described (9). Cells were infected with
 
M. tuberculosis
 
 at a MOI of 10:1 for 2 h in the presence of 5%
heat-inactivated horse serum and further cultured with or with-
out 0.5 mg/ml lactoferrin or 0.1 mg/ml rat anti-TfR antibody
(Tib219; American Type Culture Collection) for 3 d. Cells were
 
lysed in 0.5% Triton X-100 in PBS at the time points indicated
and plated onto Middlebrook 7H11 plates.
 
Analysis of Iron Content
 
Tissue.
 
Organs were weighed, lyophilized, and digested in
nitric acid and H
 
2
 
O
 
2
 
. After evaporation iron was measured in an
Atomic Absorption Spectrometer (AAS) “Unicam 939 SOLAR”
(Thermo) using an acetylene/air flame at 248.3 nm. The calibra-
tion range was linear up to 40 
 

 
mol/l iron.
 
Serum.
 
Serum iron was measured with the colorimetric Fer-
roZine assay and the Hitachi 747E analyser (Roche Diagnostics).
 
Histology
 
Snap frozen tissues from wild-type or 
 

 
2m–KO mice were
cryosectioned and stained for Fe
 
3
 

 
 using Prussian blue (Merck)
according to the manufacturer’s protocol.
 
Flow Cytometry
 
Bone marrow–derived macrophages were treated with 1,000
U/ml IFN-
 

 
, mycobacteria, or lactoferrin for 48 h. Cells were
harvested by placing them in cold PBS, blocked for 30 min in
PBS plus 5% goat serum, and incubated with Cy-5–labeled rat
anti–murine TFR mAb Tib219 (American Type Culture Collec-
tion) for 1 h. Flow cytometry was performed using FACScan™
(Becton Dickinson) and analyzed using CELLQuest™ software.
 
Results
 
To evaluate the iron status of 
 

 
2m–KO mice, the total
Fe content of the organs from 
 

 
2m–KO mice and B6 con-
trols was compared by Prussian blue staining and chemical
analysis. Consistent with previous findings, 
 

 
2m–KO mice
revealed Fe overload, notably in liver and spleen (10–12;
Fig. 1, A and B). To determine whether iron overload
contributes to increased susceptibility to tuberculosis,
Fe
 
3
 

 
Ci was administered to B6 mice via the drinking wa-
ter. When compared with untreated animals, this diet led
to enhanced Fe values in liver, spleen, and lung (Fig. 1 C).
These mice were infected by aerosol with a low dose of 
 
M.
tuberculosis
 
. At 15 d after infection, the mycobacterial bur-
dens in the lungs were approximately 10-fold higher in Fe-
overloaded as compared with nontreated mice (Fig. 1 D).
Hence, experimental Fe overload exacerbated tuberculosis
in immunocompetent mice, consistent with one other
study (13) and reflecting the situation in 
 

 
2m–KO animals.
In line with these in vivo observations, the addition of ex-
cess Fe to complete mycobacterial medium enhanced bac-
terial growth. Although not statistically significant, the in-
crease in growth rate in the presence of excess iron was
observed in all experiments (Fig. 2, A and B). Furthermore,
chelation of free Fe by deferroxamine inhibited growth of
 
M. tuberculosis
 
, which was rescued by adding a surplus
amount of Fe (Fig. 2 B).
We reasoned that restriction of iron supply could pre-
vent growth of 
 
M. tuberculosis
 
 in vivo, therefore extracellu-
lar Fe was depleted by the intranasal administration of
lactoferrin to B6 and 
 

 
2m–KO mice prior, and subse-
quent, to low dose aerosol infection with 
 
M. tuberculosis
 
.
Lactoferrin treatment did not significantly alter mycobac-
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terial burdens in B6 mice. In marked contrast, bacterial
loads were 100-fold lower in lactoferrin treated 
 

 
2m–KO
animals as compared with untreated 
 

 
2m–KO mice (Fig.
3, A and B). The numbers of 
 
M. tuberculosis
 
 in the organs
of lactoferrin-treated 
 

 
2m–KO mice were comparable to
those seen in organs of nontreated MHC-I–KO mice. At
this early time point, untreated 
 

 
2m–KO mice had at least
fivefold higher bacterial numbers in the respective organs
than B6 and MHC-I–KO mice (Fig. 3 B). Thus, treat-
ment with lactoferrin ameliorated 
 
M. tuberculosis
 
 infection
in 
 

 
2m–KO mice reducing bacterial loads to those seen in
B6 and MHC-I–KO mice. Similarly, depletion of Fe by
deferroxamine decreased mycobacterial numbers in 
 

 
2m–
KO and B6 mice (unpublished data). This is in contrast to
a recent study on murine salmonellosis, which revealed
strong exacerbation of infection by deferroxamine treat-
ment through inhibition of the respiratory burst in host
cells (14).
As correlates of the protective host response, nitric oxide
(
 
·
 
NO) and IFN-
 

 
 were measured in sera from 
 

 
2m–KO
mice infected with 
 
M. tuberculosis
 
. IFN-
 

 
 levels were com-
parable in both treated and untreated mice (unpublished
data). However, 
 
·
 
NO was undetectable in sera from 
 

 
2m
KO mice infected with 
 
M. tuberculosis
 
, whereas B6 mice
produced low but detectable levels (Fig. 3 C). In contrast,
lactoferrin increased 
 
·
 
NO production in 
 
M. tuberculosis
 
–
infected 
 

 
2m–KO mice resulting in even higher serum levels
in comparison with treated or untreated B6 mice. We con-
clude that lactoferrin not only sequesters extracellular Fe,
but also promotes 
 
·
 
NO production. Lactoferrin has been
previously shown to contain a microbicidal peptide (15–
17). In contrast to the complete protein, however, intrana-
sal treatment with this peptide (FKCRRWQWRM) after
aerosol infection with 
 
M. tuberculosis
 
 did not reduce growth
of 
 
M. tuberculosis
 
 in 
 

 
2m–KO mice (data not depicted).
This suggests that the Fe binding property of lactoferrin is
Figure 1. Iron overload in 2m KO mice and susceptibility to M. tuberculosis of experimen-
tally iron overloaded mice. (A) Iron-specific staining by Prussian blue of liver sections revealed
iron overload in 2m–KO as compared with B6 mice (representative specimens from one out of
five mice per group). (B) Iron overload in 2m–KO mice was verified by measuring iron con-
tent in organs of each mouse strain (data from five mice  SD out of three experiments). (C) El-
evated iron concentrations in organs from mice treated with Fe3Ci (values from five mice 
SD, one out of three experiments). (D) Experimental iron overload increased growth of M. tu-
berculosis in B6 mice. Mice (n  5) were infected with M. tuberculosis by aerosol and treated with
Fe via the drinking water. Bacterial load was measured in the lungs at day 15 (**P 	 0.005 as de-
termined by the non paired Mann-Whitney test; one representative experiment out of three).
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responsible for the inhibition of mycobacterial growth in
the 2m–KO mouse.
Macrophages are the primary host cells for M. tuberculosis
and Fe supply is provided by the Tf/TfR/HFE uptake sys-
tem in these cells (18). Macrophages from B6 and 2m–
KO mice were infected in the presence or absence of lacto-
ferrin and viable intracellular M. tuberculosis organisms were
enumerated at days 1, 2, and 3. In untreated cultures, num-
bers of mycobacteria increased 50- to 100-fold by day 3,
whereas lactoferrin reduced and finally terminated growth
of M. tuberculosis between days 2 and 3 after infection (Fig.
4). Hence, depletion of extracellular Fe by lactoferrin is
detrimental for M. tuberculosis growth in macrophages in
vitro, even in the absence of activation by IFN-. Similar
to lactoferrin, treatment with an anti-TfR monoclonal an-
tibody also restricted growth of M. tuberculosis in macro-
phages (Fig. 4). As lactoferrin has no effect on mycobacte-
rial growth in broth culture (Fig. 2 A), these results strongly
suggest that interference with Fe transport into infected
macrophages leads to inhibition of mycobacterial growth.
The TfR associates with HFE to facilitate correct Tf/Fe
import into the cell, a process disrupted in cells carrying
mutated HFE or lacking 2m. To study the influence of
lactoferrin on this system, TfR expression on B6 and 2m–
KO macrophages was measured after treatment with IFN-
and/or mycobacteria. Surface expression of TfR was re-
duced in 2m–KO macrophages. The small constitutive
surface expression of the TfR on 2m–KO macrophages
remained unaltered after treatment with IFN- or myco-
bacteria (Fig. 5). However, in B6 macrophages, IFN- de-
Figure 2. Depletion of iron inhibits and excess
iron enhances growth of M. tuberculosis in broth cul-
ture. Mycobacterial growth was monitored by OD600
(A) and CFU (B) in the presence or absence of
Fe3Ci, deferroxamine (def), a mixture of both or
lactoferrin. Results indicate mean  SD of three in-
dividual cultures. Shown are representative indepen-
dent experiments out of three for each set up.
Figure 3. Lactoferrin decreased growth of M. tuberculosis in 2m KO but not in MHC class I KO mice. (A) Lactoferrin treatment reduced the growth
of M. tuberculosis in 2m–KO but not B6 mice. Mice were infected with 159 bacteria/lung by aerosol and bacterial load was measured at 22 d after infec-
tion (untreated, closed symbols; lactoferrin treatment, open symbols). (B) Lactoferrin treatment decreased growth of M. tuberculosis in 2m–KO but less
so in B6 or MHC class I KO mice. Mice were infected with 155 bacteria/lung by aerosol and bacterial load was measured at 27 d after infection (un-
treated, closed symbols; lactoferrin treatment, open symbols). Statistics: *P 	 0.01, **P 	 0.005 as determined by the non paired Mann-Whitney test
(data from one representative experiment out of three). (C) Serum levels of NO measured as NO2 in mice at 27 d after infection by aerosol with five M.
tuberculosis/lung (untreated, closed symbols; lactoferrin treated, open symbols).
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creased and mycobacterial infection up-regulated surface
expression of TfR. Interestingly, mycobacteria-induced
TfR up-regulation was down-modulated by lactoferrin
(Fig. 5), probably as a counter mechanism to reduce Fe up-
take by infected cells, similar to observations in mycobacte-
ria-infected macrophages upon IFN- activation (19). In
addition to depleting Fe from the extracellular environ-
ment, lactoferrin-mediated TfR down-regulation limits Fe
availability to intracellular mycobacteria adding a new anti-
bacterial property to lactoferrin.
Discussion
Since the early days of tuberculosis, a correlation be-
tween host iron status and exacerbation of the disease has
been recognized, but widely forgotten (20, 21). On the
one hand, host cells require Fe as a cofactor for mycobacte-
ricidal effector mechanisms, while on the other hand the
pathogen must gain access to Fe to ensure its intracellular
survival. Therefore, host and mycobacteria compete for
this critical element. Here we show that when this balance
is tipped in favor of the pathogen, under conditions of he-
reditary or experimental Fe overload, M. tuberculosis flour-
ishes in vivo. Our findings provide strong evidence, that
iron is a crucial growth factor for M. tuberculosis, and ex-
plain why exploitation of the iron-rich early endosomal
compartment of host macrophages by mycobacteria repre-
sents an important survival strategy for these pathogens. In-
traphagosomal mycobacteria take up Fe from exogenous
transferrin (reference 1, and D.G. Russell, Cornell Univer-
sity, Ithaca, NY, personal communication), and mycobac-
terial phagosomes concentrate Fe as demonstrated by
electron energy loss spectroscopy (unpublished data).
Mycobacteria require iron as obligate cofactor for at least
40 different enzymes encoded by the M. tuberculosis ge-
nome (21). However, in the intracellular environment,
mycobacteria are faced with limited access to this nutritive
element. In response to this predicament, M. tuberculosis ex-
presses a number of high affinity, iron-binding sidero-
phores such as mycobactins to compete for iron with host
cell iron capture systems (3, 21). The imminent need for
iron by pathogenic mycobacteria is documented by M. tu-
berculosis mutants deficient for siderophores, which are at-
tenuated for growth in macrophages (22). Mycobacterial
genes involved in iron acquisition and storage such as those
involved in biosynthesis of siderophores and iron storage
proteins are regulated by the iron-dependent-repressor
(IdeR), a transcription suppressor with high homology to
the corynebacterial diphtheria-toxin-repressor (DtxR; ref-
erences 23 and 24). M. tuberculosis mutants expressing a
constitutively active DtxR are attenuated in mice (24). The
fact that a number of IdeR controlled genes are strongly
up-regulated upon iron starvation as well as inside mac-
rophages further indicates the importance of iron for the
intracellular survival of mycobacteria (23). Furthermore,
treatment of infected macrophages with Tf saturated with
gallium, which substitutes for Fe without undergoing re-
dox recycling, inhibits the intracellular growth of M. tuber-
culosis in vitro (25).
Hereditary iron overload in 2m–KO mice meets the
demand for Fe of intracellular M. tuberculosis thereby sup-
porting their replication and, as a consequence, exacerbat-
ing tuberculosis. However, decreasing the extracellular Fe
pool by treatment with lactoferrin limited available iron for
transport into the host cell, and reduced the growth of M.
tuberculosis to levels seen in normal mice. Although a higher
risk of developing tuberculosis has not been described in
hemochromatosis patients to date, epidemiological studies
in human populations show a correlation between dietary
Figure 4. Lactoferrin decreased growth of M. tuberculosis in macro-
phages from both B6 and 2m-KO mice. Bone marrow–derived mac-
rophages were infected with M. tuberculosis at a MOI of 2:1. 2 h after in-
fection the cells were washed and further cultured for 4 d in the absence
or presence of lactoferrin or an anti-TfR antibody. Mycobacterial growth
was measured by CFU at the indicated time points (data  SD from one
representative experiment out of four).
Figure 5. Reduced TfR expression on macrophages from 2m–KO
mice. Bone marrow–derived macrophages from B6 and 2m KO mice
were treated with IFN-, lactoferrin, and/or mycobacteria (10:1) for 48 h
and analyzed by flow cytometry using the rat anti–murine TfR Tib-219
(data  SD from one representative experiment out of three).
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Fe overload and susceptibility to, and prevalence of, tuber-
culosis in subsaharan Africa (26).
The finding that NO production in infected 2m–KO
mice is impaired but can be rescued by lactoferrin indicates
that iron overload can hamper NO synthesis by a so far un-
known mechanism. Similar to hemochromatosis patients,
experimentally iron overloaded mice suffer from constitu-
tive oxygen-free radical generation (27). Preliminary ex-
periments show that constitutive generation of reactive ox-
ygen intermediates (ROIs) in 2m–KO peripheral blood
leukocytes can be reduced by lactoferrin suggesting a nega-
tive feedback mechanism by which ROI can control NO
production (unpublished data).
Apart from classical MHC-I molecules and HFE, 2m
also associates noncovalently with a number of nonclassical
MHC-Ib and other MHC-I–like molecules such as Qa,
H2-M3, and CD1. Therefore, a lack of these molecules
could also contribute to the higher susceptibility of 2m–
KO mice as compared with MHC-I–KO mice. However,
mice lacking CD1d or CD8 T cells including H2-M3–
specific CD8 T cells are less susceptible to M. tuberculosis
than 2m–KO mice (28–30). This further supports the
idea that defective surface expression of HFE causes an im-
balance in Fe transport which forms the basis for unre-
strained growth of M. tuberculosis in 2m–KO mice as
compared with B6 or MHC-I–KO mice. Our data pro-
vide further insights into the multifaceted biology of tu-
berculosis and provide guidelines for rational development
of novel treatment regimes for this threatening disease, es-
pecially in areas of the world where dietary Fe overload
and tuberculosis are concurrent problems.
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